Tag: pharmaceutical and biotech companies

April 30, 2018

Key Stock Catalysts in the FDA Drug Application Process

Pharmaceutical and biotech companies in the US must follow a standard process to advance a new drug candidate through nonclinical...
February 20, 2018

3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma

3D Signa­­­­­­tures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that a preliminary third-party analysis of...
October 10, 2017

3D Signatures Announces Completion of Stage 3 of Hodgkin’s Lymphoma Test Validation Program

3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or “3DS”), is pleased to announce that, on September 30, 2017, the...
June 19, 2017

MedReleaf Obtains Good Manufacturing Practices Certification

MedReleaf announced it became the first medical cannabis producer to receive an International Council on Harmonization certification for Good Manufacturing...
February 16, 2017

Cancer Genetics' Hereditary Breast & Ovarian Cancer Panel Selected by Global Biopharma to Power 1,000+ Patient Clinical Study

Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a leader in precision diagnostics for oncology, announced today that its hereditary...
February 3, 2017

An Analyst’s Take on Drug Pricing and Catalysts in the Biotech Industry

In the first of a two-part series, analyst Hartaj Singh talks about the biotech industry in 2016 and 2017, drug...
December 29, 2016

Top Genetics News Stories of 2016

From precision meds to the ongoing CRISPR-Cas9 saga, here are the top genetics news stories of 2016. We expect each...